265 related articles for article (PubMed ID: 22973873)
1. New treatments for influenza.
Barik S
BMC Med; 2012 Sep; 10():104. PubMed ID: 22973873
[TBL] [Abstract][Full Text] [Related]
2. Influenza: emergence and control.
Lipatov AS; Govorkova EA; Webby RJ; Ozaki H; Peiris M; Guan Y; Poon L; Webster RG
J Virol; 2004 Sep; 78(17):8951-9. PubMed ID: 15308692
[No Abstract] [Full Text] [Related]
3. Outpacing antiviral resistance: new treatments for influenza virus infection.
Coughlan L; Neuzil KM
Lancet Infect Dis; 2024 May; 24(5):447-449. PubMed ID: 38330976
[No Abstract] [Full Text] [Related]
4. Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugs.
Gasparini R; Amicizia D; Lai PL; Bragazzi NL; Panatto D
J Prev Med Hyg; 2014 Sep; 55(3):69-85. PubMed ID: 25902573
[TBL] [Abstract][Full Text] [Related]
5. The past, present and future of RNA respiratory viruses: influenza and coronaviruses.
Makarov V; Riabova O; Ekins S; Pluzhnikov N; Chepur S
Pathog Dis; 2020 Oct; 78(7):. PubMed ID: 32860686
[TBL] [Abstract][Full Text] [Related]
6. Intervention strategies for an influenza pandemic taking into account secondary bacterial infections.
Handel A; Longini IM; Antia R
Epidemics; 2009 Sep; 1(3):185-95. PubMed ID: 20161493
[TBL] [Abstract][Full Text] [Related]
7. Editorial: Host-cell pathways modulated by influenza virus infection: new insight into pathogenetic mechanisms and cell-targeted antiviral strategies.
De Angelis M; Checconi P; Olagnier D
Front Cell Infect Microbiol; 2024; 14():1372896. PubMed ID: 38435304
[No Abstract] [Full Text] [Related]
8. Rosin Derivatives as a Platform for the Antiviral Drug Design.
Popova L; Ivanchenko O; Pochkaeva E; Klotchenko S; Plotnikova M; Tsyrulnikova A; Aronova E
Molecules; 2021 Jun; 26(13):. PubMed ID: 34201875
[TBL] [Abstract][Full Text] [Related]
9. The cytokine storm of severe influenza and development of immunomodulatory therapy.
Liu Q; Zhou YH; Yang ZQ
Cell Mol Immunol; 2016 Jan; 13(1):3-10. PubMed ID: 26189369
[TBL] [Abstract][Full Text] [Related]
10. Unveiling innovative anti-influenza agents through modern medicinal chemistry approaches (2019-2023 updates).
Liu C; Hu L; Jia H; Zhang J; Dong G; da Silva-Júnior EF; Liu X; Zhan P
Future Med Chem; 2023 Nov; 15(21):1915-1917. PubMed ID: 37929606
[No Abstract] [Full Text] [Related]
11. Detection of the influenza virus yesterday and now.
Woźniak-Kosek A; Kempińska-Mirosławska B; Hoser G
Acta Biochim Pol; 2014; 61(3):465-70. PubMed ID: 25180218
[TBL] [Abstract][Full Text] [Related]
12. Outlining recent updates on influenza therapeutics and vaccines: A comprehensive review.
Malik S; Asghar M; Waheed Y
Vaccine X; 2024 Mar; 17():100452. PubMed ID: 38328274
[TBL] [Abstract][Full Text] [Related]
13. Fasting mimicking diet in mice delays cancer growth and reduces immunotherapy-associated cardiovascular and systemic side effects.
Cortellino S; Quagliariello V; Delfanti G; Blaževitš O; Chiodoni C; Maurea N; Di Mauro A; Tatangelo F; Pisati F; Shmahala A; Lazzeri S; Spagnolo V; Visco E; Tripodo C; Casorati G; Dellabona P; Longo VD
Nat Commun; 2023 Sep; 14(1):5529. PubMed ID: 37684243
[TBL] [Abstract][Full Text] [Related]
14. Opportunistic etiological agents causing lung infections: emerging need to transform lung-targeted delivery.
Debnath SK; Debnath M; Srivastava R
Heliyon; 2022 Dec; 8(12):e12620. PubMed ID: 36619445
[TBL] [Abstract][Full Text] [Related]
15. An anti-influenza A virus microbial metabolite acts by degrading viral endonuclease PA.
Zhao J; Wang J; Pang X; Liu Z; Li Q; Yi D; Zhang Y; Fang X; Zhang T; Zhou R; Zhang T; Guo Z; Liu W; Li X; Liang C; Deng T; Guo F; Yu L; Cen S
Nat Commun; 2022 Apr; 13(1):2079. PubMed ID: 35440123
[TBL] [Abstract][Full Text] [Related]
16. Impact of Infectious Disease after
Thu NN; Mai TT; Trang TTT; Tuan NA; Quyen TC; Hanh NL; Hoan NH; Lan BTH; Hau PT; Tue HH; Dung TV; Tsuji R; Watanabe Y; Yamamoto N; Kanauchi O
Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276914
[No Abstract] [Full Text] [Related]
17. Nanotechnology Integration for SARS-CoV-2 Diagnosis and Treatment: An Approach to Preventing Pandemic.
Asdaq SMB; Ikbal AMA; Sahu RK; Bhattacharjee B; Paul T; Deka B; Fattepur S; Widyowati R; Vijaya J; Al Mohaini M; Alsalman AJ; Imran M; Nagaraja S; Nair AB; Attimarad M; Venugopala KN
Nanomaterials (Basel); 2021 Jul; 11(7):. PubMed ID: 34361227
[TBL] [Abstract][Full Text] [Related]
18. Progression and Trends in Virus from Influenza A to COVID-19: An Overview of Recent Studies.
Daemi HB; Kulyar MF; He X; Li C; Karimpour M; Sun X; Zou Z; Jin M
Viruses; 2021 Jun; 13(6):. PubMed ID: 34203647
[TBL] [Abstract][Full Text] [Related]
19. The CRISPR revolution and its potential impact on global health security.
Watters KE; Kirkpatrick J; Palmer MJ; Koblentz GD
Pathog Glob Health; 2021 Mar; 115(2):80-92. PubMed ID: 33590814
[TBL] [Abstract][Full Text] [Related]
20. The effect of probiotics on respiratory tract infection with special emphasis on COVID-19: Systemic review 2010-20.
Darbandi A; Asadi A; Ghanavati R; Afifirad R; Darb Emamie A; Kakanj M; Talebi M
Int J Infect Dis; 2021 Apr; 105():91-104. PubMed ID: 33578007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
